RHC 3281: tiaramide metabolite; structure given in first source
ID Source | ID |
---|---|
PubMed CID | 169502 |
SCHEMBL ID | 10546635 |
MeSH ID | M0109398 |
Synonym |
---|
rhc 3281 |
piperazine, 1-((5-chloro-2-oxo-3-benzothiazolinyl)acetyl)- |
1-((5-chloro-2-oxo-3(2h)-benzothiazolyl)acetyl)piperazine |
piperazine, 1-((5-chloro-2-oxo-3(2h)-benzothiazolyl)acetyl)- |
3-(1-piperazinyl)carbonylmethyl-5-chloro-2-benzothiazolinone |
33353-30-9 |
unii-ewc4ea0cqg |
rhc-3281 |
ewc4ea0cqg , |
desethanol tiaramide |
RPRUIZPTDDIOHH-UHFFFAOYSA-N |
5-chloro-3-[(1-piperazinyl)carbonylmethyl]-2-benzothiazolinone |
SCHEMBL10546635 |
DTXSID60186970 |
2(3h)-benzothiazolone, 5-chloro-3-(2-oxo-2-(1-piperazinyl)ethyl)- |
3-(1-piperazinyl)carbonylmethyl-5-chloro-2(3h)-benzothiazolinone |
desethanol-tiaramide |
5-chloro-3-(2-oxo-2-(1-piperazinyl)ethyl)-2(3h)-benzothiazolone |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (50.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.41) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |